Molecular Formula | C20H13F4N3O3S |
Molar Mass | 451.39 |
Density | 1.59±0.1 g/cm3(Predicted) |
Melting Point | 210-212°C |
Boling Point | 590.2±60.0 °C(Predicted) |
Solubility | DMSO (Sparingly), Ethyl Acetate (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | White |
pKa | 2.94±0.10(Predicted) |
Storage Condition | 2-8°C |
Stability | Light Sensitive |
In vitro study | Enzalutamide is converted into its major metabolites, N-desmethyl enzalutamide and carboxylic acid enzalutamide, by cytochrome P450 (CYP) 3A4/5 and CYP2C8, respectively. N-desmethyl enzalutamide has clinically relevant anti-androgen capacities similar to enzalutamide, whereas carboxylic acid enzalutamide is inactive. |
Use | enzalutamide carboxylic acid is a carboxylic acid amine organic substance, which can be used as an impurity reference substance. |
biological activity | Enzalutamide carbonic acid (MDV3100 carbonic acid) is an inactive metabolite of Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist. |